Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research

to
Auditorium I
Major session

Advances in drug treatment

to
Auditorium II
Oral presentation session

Innovative health approaches

to
Auditorium III
Oral presentation session

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Treatment of alcohol use disorder

to
Room 1.05
Short communication session

Support for recovery

to
Room 1.07
Short communication session

14:20

Neuroscience and cognition

to
Auditorium III
Short communication session

Neuroscience and cognition

to
Auditorium III
Short communication session

Neuroscience and cognition

to
Auditorium III
Short communication session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Tobacco, mental health and other substance use

to
Auditorium VII
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Alcohol use disorder: clinical biology and epidemiology

to
Room 1.05
Short communication session

Meetings the needs of women who use drugs or alcohol

to
Room 1.06
Short communication session

Methods and measurement

to
Room 1.08
Short communication session

Methods and measurement

to
Room 1.08
Short communication session

16:00

Alcohol use from brief intervention to harm reduction

to
Auditorium II
Oral presentation session

The recovery journey

to
Auditorium III
Oral presentation session

The recovery journey

to
Auditorium III
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Inequalities and needs of migrant groups

to
Room 5C
Oral presentation session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

Trauma and addiction - developing skills in the screening of traumatic experiences in addiction care

to
Room 1.10
Workshop

17:50

The EUFAS-EAR European Addiction Research Award

to
Auditorium I
Major session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Understanding interrelationships: mental health and substance use

to
Auditorium VII
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Capacity-building through competencies for the substance use workforce

to
Room 1.10
Workshop

Thu 24 Oct

11:50

International collaboration to understand and address the co-occurrence of addiction with ADHD and autism spectrum disorders

to
Auditorium I
Major session

Predicting the future: biomarkers for progression of alcohol use disorder

to
Auditorium II
Oral presentation session

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

Natural language processing for addiction research: a practical primer

to
Room 1.06
Workshop

Contemporary issues

to
Room 1.08
Oral presentation session

Back-casting exercise on peer-support workforce development

to
Room 1.15
Workshop

14:20

New opportunities for informing clinical practice and policy development in the area of behavioural addictions

to
Auditorium I
Major session

Novel neurobiology - cannabis, cognition and craving

to
Auditorium III
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Young people, mental health and substance use

to
Auditorium VII
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

Women's realities of drug use

to
Room 1.08
Oral presentation session

Women's realities of drug use

to
Room 1.08
Oral presentation session

16:00

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Cannabis legalisation — models and impacts

to
Auditorium VI
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

A unique care model for inpatient addictions and tri-morbidity within an acute UK hospital

to
Room 5C
Oral presentation session

From genes to brains

to
Room 1.06
Short communication session

17:50

Alcohol and gender issues

to
Auditorium II
Oral presentation session

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Alcohol use among the elderly

to
Auditorium VI
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

New Research on Alcohol and Tobacco Policy

to
Room 5A
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder

to
Room 1.08
Oral presentation session

Fri 25 Oct

11:50

The ripple effect: International developments in the opioid market and their potential implications for European public health and security

to
Auditorium I
Major session

Alcohol: interventions and up-to-date technologies

to
Auditorium II
Oral presentation session

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Psychedelics 2

to
Auditorium VI
Oral presentation session

Trauma and substance use

to
Auditorium VII
Oral presentation session

Trauma and substance use

to
Auditorium VII
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Gaming and health

to
Room 1.06
Short communication session

How can cannabis policy goals inform the development of evaluation indicators?

to
Room 1.08
Workshop

Intimate partner violence perpetration: The ADVANCE-Digital Programme for men

to
Room 1.15
Workshop

14:20

Alcohol and other drug policies in the work setting – a perspective on European developments

to
Auditorium II
Oral presentation session

Overdose prevention

to
Auditorium IV
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Regulating cannabis supply policies in Europe: navigating the long road to change

to
Auditorium VIII
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Impact of drug policy on drug production & markets

to
Room 5B
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session

Holistic care for mental well-being

to
Room 1.05
Short communication session

Future of opioid markets in Europe: Foresight approaches

to
Room 1.10
Workshop